HOME NEWS EARNINGS RESULTS PICKS STRATEGY BLOG CONTACT SUBSCRIBE LOGIN SUBSCRIBE JOIN FREE
LOADING
Price Investing Group
← Back to Research Watchlist
BIIB
Biogen Inc
Healthcare Drug Manufacturers - General · Massachusetts, USA · Reports in usd
Market Cap: $27.05B
Market Cap
$27.05B
Enterprise Val
$29.81B
P/E Ratio
20.92
P/B Ratio
1.48
Trailing PEG (1Y)
-0.18
As Of
Apr 23, 2026

Overview & Key Metrics

Reporting period: Dec 31, 2025 · Q4 2025
Book Value$18.26B
Gross Margin78.26%
Profit Margin78.26%
Return on Equity7.28%
Return on Assets4.50%
Current Ratio2.68
Debt/Equity0.36
LT Debt/Equity0.36
Revenue Per Share15.54

Income Statement

Dec 31, 2025
Revenue$2.28B
Cost of Revenue$495.5M
Gross Profit$1.78B
R&D$509.4M
SG&A$682.5M
Operating Expenses$1.84B
Operating Income-$56.0M
Interest Expense$0.00
Tax Expense-$7.1M
Net Income-$48.9M
EPS (Basic)$-0.33
EPS (Diluted)$-0.35
EBIT-$56.0M
EBITDA$148.6M
Consolidated Income-$48.9M
Non-Controlling Interests$0.00

Balance Sheet

Dec 31, 2025
Cash & Equivalents$3.01B
Accounts Receivable$1.87B
Inventory$2.17B
Current Assets$8.97B
LT Investments$1.18B
Property, Plant & Equipment$3.32B
Intangibles$15.67B
Non-Current Assets$20.47B
Total Assets$29.44B
Accounts Payable$432.0M
Current Debt$0.00
Current Liabilities$3.35B
LT Debt$6.58B
Non-Current Liabilities$7.83B
Total Liabilities$11.18B
Total Debt$6.58B
Retained Earnings$20.55B
Shareholder Equity$18.26B
Shares Outstanding146,702,272

Cash Flow Statement

Dec 31, 2025
Operating Cash Flow$511.9M
Investing Cash Flow-$1.23B
Financing Cash Flow-$137.0M
CapEx-$60.2M
Free Cash Flow$451.7M
Depreciation & Amort.$204.6M
Stock-Based Comp$59.6M
Acquisitions / Disposals$0.00
Investment Activity-$1.14B
Debt Issued/Repaid$0.00
Equity Issued/Repaid$0.00
Dividends Paid$0.00
Net Change in Cash-$856.8M
Data cached · Meta cache · Daily cache · Statements cache · TTL 24h